申请人:Bates Roderick Wayland
公开号:US20110268663A1
公开(公告)日:2011-11-03
Intravascular contrast agents are provided by Gd-chelates modified so as to comprise an amino acid unit attached to the chelate via a linker group suitably selected from C
2-4
alkylene and C
3-5
alkynylene. The chelates may be used as an intravascular contrast agent for MRI. Certain embodiments demonstrate enhanced relaxivity and good levels of signal enhancement.